SEC Form 4 · accession 0001209191-18-062531
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian B Hansen
Officer — EVP & CHIEF COMMERCIAL OFFICER
Period of report
Dec 12, 2018
Accepted (ET)
Dec 13, 2018 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 12, 2018 | M | 25,000 | $2.59 | A | 26,381 | D | |
| Common Stock | Dec 12, 2018 | S | 25,000 | $37.75 | D | 1,381 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $2.59 | Dec 12, 2018 | M | 25,000 | D | — | Dec 1, 2027 | Common Stock | 25,000 | 75,000 | D |
Explanation of responses
- F1Represents shares of common stock received upon exercise of a stock option award.
- F2The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018.
- F3Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.